Description
Brimonidine, with its active ingredient brimonidine tartrate, is primarily prescribed for the management of glaucoma and ocular hypertension. As a selective alpha-2 adrenergic receptor agonist, it decreases fluid production in the eye and increases fluid drainage, effectively lowering elevated intraocular pressure. This mechanism prevents damage to the optic nerve, which can lead to vision loss. Brimonidine is available as eye drops and is used in the affected eye(s) as directed.
Reviews
There are no reviews yet.